SMKUY yields 45.63% · JNJ yields 2.13%● Live data
📍 SMKUY pulled ahead of the other in Year 1
Combined, SMKUY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SMKUY + JNJ for your $10,000?
Siam Makro Public Company Limited operates cash and carry trade centers under the Makro name. It operates through Cash and Carry, Retail, Mall Rental, and Food Services segments. The company's trade centers sell food and non-food products to registered members, including small and medium-sized businesses, retailers, caterers, professional sectors, and institutions. It offers freight, delivery rental, and storage services; marketing and consulting services; and imports, exports, trades in, and distributes food products. The company is also involved in the provision of technical and support services; trading of non-food products; investing and operation of retail business and mall rental activities; importing and trading of frozen and chilled foods; telecommunication business; and operation of restaurant and minimart. As of December 31, 2021, it operated 135 Makro stores and 7 frozen shops. The company was incorporated in 1988 and is headquartered in Bangkok, Thailand. Siam Makro Public Company Limited is a subsidiary of CP ALL Public Company Limited.
Full SMKUY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.